Oral peptide strips marketed with BPC-157 outside FDA-approved formulations
The film format is a distinct drug product from any approved peptide, and reliable absorption through oral mucosa remains unresolved, the report notes.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 9 17:34 ETSource: Raleigh News & Observer
The wire
- 01A consumer report catalogs companies selling dissolvable oral peptide films, including strips., Instamed's InstaRelease platform launched May 2025, Zenvy, Cold Spring Wellness and Viva Health Co., with BPC-157 among named ingredients.
- 02Pharmacists and clinicians fielding patient questions should note that FDA approval attaches to a specific formulation, route and manufacturer, so a strip version of an approved peptide is a separate, unapproved product.
- 03Bioavailability through oral films remains a significant challenge per 2026 research cited; BioNxt Solutions reports only proof-of-concept for a semaglutide dissolvable film, and marketing claims here are company statements.
From the source
Read at newsobserver.comNo needles? How peptide strips work and what’s behind these dissolving films in 2026
Peptide strips are turning up across wellness and biohacking channels in 2026, promising injection-free delivery through dissolving oral films. Here is what research, the FDA and the brands actually say.
